{"id":"W1549851394","doi":"10.1093/annonc/mdu364","title":"Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Roche","keywords":"Medicine; Trastuzumab; Adjuvant; Breast cancer; Cohort; Oncology; Cohort study; Cancer; Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003401956,0.0007350388,0.001486602,0.0001684609,0.0003166349,0.0009058401,0.0007154455,0.0009663012,0.002612492],"category_scores_gemma":[0.004507002,0.0004178715,0.002377397,0.0003407833,0.0008302135,0.0009093141,0.0003395375,0.001631407,0.0002861177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004887739,"about_ca_system_score_gemma":0.0004374839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000703198,"about_ca_topic_score_gemma":0.001077833,"domain_scores_codex":[0.9977304,0.001515084,0.00009294301,0.000275643,0.0001639613,0.0002219857],"domain_scores_gemma":[0.9961286,0.002399376,0.0007149656,0.0003586177,0.00005950015,0.0003389397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8369004,0.003632272,0.1243654,0.0001987311,0.004763701,0.0002500663,0.0002969037,0.002211966,0.003361839,0.0003049451,0.001074208,0.02263949],"study_design_scores_gemma":[0.3056042,0.1272689,0.5305236,0.0001110928,0.01132474,0.0008922055,0.001177928,0.01415094,0.003725556,0.002563138,0.002374538,0.0002831051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991774,0.0002483145,0.0001201909,0.00005106832,0.00001280526,0.00003756736,0.0001660054,0.000003100309,0.0001834352],"genre_scores_gemma":[0.9992051,0.00009669508,0.0001137802,0.00008823184,0.00001904231,0.00003558476,0.0002797295,0.000003117586,0.0001587651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003401956,"threshold_uncertainty_score":0.01799142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08889308378065346,"score_gpt":0.4284548250882904,"score_spread":0.3395617413076369,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}